Medtronic Cuts Away More: Spins Off Patient Monitoring And Respiratory Business
Executive Summary
Medtronic announced plans to spin off its patient monitoring and respiratory interventions businesses, which currently provide revenues of over $2bn a year. The company previously signaled plans to make significant changes to its business portfolio.
You may also be interested in...
Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity
Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.
Exec Chat: Medtronic’s Chan Discusses Future Of Connected Care In A Stressed System
Frank Chan, the president of Medtronic’s Patient Monitoring, talked to Medtech Insight about Medtronic’s planned spin-off of its Patient Monitoring business, some lessons from the pandemic, and the potential for digital data to improve patient outcomes.
Global Top 10 Medtechs Swap Places After Latest Quarterlies
Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.